comparemela.com

Latest Breaking News On - Novartis pharma india - Page 1 : comparemela.com

India-focused PE Jashvik Capital holds first close of $350m maiden fund

Jashvik Capital launched the fund in July and expects to close within a year.

West bengalNaresh patwariLal pathlabsAjay relanVijender singhOmniactive health technologiesMckinsey companyDevyani internationalTa associatesJashvik capitalShilpa medicareAnil mataiNovartis pharma indiaZydus healthcareMetropolis healthcareXponentia capital

Jashvik Capital appoints Anil Matai, Vijender Singh on board

Vijender Singh was the CEO of Metropolis Healthcare and COO of Dr Lal Pathlabs while Matai was the MD of Zydus Healthcare and CEO of Novartis Pharma India

India generalLal pathlabsVijender singhBausch lombJashvik capitalAnil mataiMetropolis healthcareRanbaxy labsManaging directorZydus healthcareNovartis pharmaAnil mataiBijender singhMetropolis healthcareZydus healthcareNovartis pharma india

Jashvik Capital onboards Anil Matai, Vijender Singh as Operating Partners

Both Singh and Matai are industry veterans and have held led top companies in the Indian healthcare sector in the recent past in different capacities.

India generalNaresh patwariLal pathlabsJashvik capitalAnil mataiVijender singhBoth singhChief executive officerMetropolis healthcareChief operating officerManaging directorZydus healthcareNovartis pharma indiaTroubled bollywoodAnil mataiBijender singh

vimarsana © 2020. All Rights Reserved.